Open Your FREE Demat Account Now!

Mahamaya Lifesciences Ltd. Share Price

NSE
BSE

BSE : 544611

Sector : Chemicals

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹

High

₹

Price Summary

Previous Close ₹188.55
Day's Range ₹177.00 - ₹189.40
Open ₹178.50
52 Week Range ₹111.00 - ₹205.05
Volume 69,600
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 127.50
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 26.71
TTM EPS (₹) 7.06
P/E Ratio 21.32
Book Value(₹) 3.62
PAT Margin (%) 5.02
Face Value (₹) 10.00
ROCE(%) 20.27

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales N/A 2657.51
Expenses N/A N/A
PBT N/A 172.64
Operating profit N/A 0.0
Net profit N/A 128.21

Shareholding Pattern

Promoters (% Holding)

56.39%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

38.94%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

2.66%

About Mahamaya Lifesciences Ltd.

Founded 2016
Managing Director Krishnamurthy Ganesan

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Asian Paints Ltd. 2,44,403.60 2,548.00 2,115.00 - 2,115.00
Solar Industries India Ltd. 1,73,654.04 19,190.40 11,646.00 - 11,646.00
Pidilite Industries Ltd. 1,55,632.48 1,528.00 1,259.00 - 1,259.00
SRF Ltd. 73,365.14 2,475.00 2,178.30 - 2,178.30
Coromandel International Ltd. 58,333.54 1,977.00 1,651.10 - 1,651.10
Berger Paints India Ltd. 55,466.75 475.50 391.10 - 391.10
The Fertilisers And Chemicals Travancore Ltd. 52,438.71 801.85 652.10 - 652.10
Gujarat Fluorochemicals Ltd. 51,767.91 4,719.00 2,916.60 - 2,916.60
Navin Fluorine International Ltd. 51,485.61 10,030.00 5,440.00 - 5,440.00
UPL Ltd. 46,851.40 555.00 476.45 - 476.45
no-content No Records Found

Latest News

Sep
30
2026
EQUITY Posted on Sep 30th 2026

Mahamaya Lifesciences informs about change in management

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Part A of Schedule III of the said Regulations, Mahamaya Lifesciences has informed that the members of the Company, based on the recommendations of Board of Directors & Nomination and Remuneration Committee approved the following resolutions at their meeting held on Tuesday, September 29, 2026, at 11:00 AM: Appointment of Dr. Bhagirath Choudhary as Independent Director, Re-appointment of Dr. Charudatta Digambar Mayee as Independent Director, Re-appointment of Gopal Krishna Raju as Independent Director, Re-designation of Krishnamurthy Ganesan as Chairman, and Re-designation of Prashant Krishnamurthy as Managing Director.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
13
2026
EQUITY Posted on Nov 13th 2026

Styrenix Performance Materials informs about disclosure

Pursuant to Regulation 30 read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations), and further to its letter dated February 02, 2026 regarding order passed by Assessment Unit of Income Tax Department, Styrenix Performance Materials has informed that the hon’ble Income Tax Appellate Tribunal (ITAT) vide its order has allowed the appeal filed by the Company and deleted the tax demand. A certified copy of order received on November 12, 2026. The details required under Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are provided in Annexure A to this letter.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
13
2026
EQUITY Posted on Nov 13th 2026

SRF informs about disclosures

SRF has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for KAMA Realty (Delhi).
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
13
2026
EQUITY Posted on Nov 13th 2026

Cochin Minerals & Rutiles informs about press release

Cochin Minerals & Rutiles has informed that it enclosed the Extract of Unaudited Standalone Financial Results for the quarter and half year ended September 30,2026 published in Financial Expresss (English) & Kerala Kaumudi (Malayalam) on Friday, November 13,2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
13
2026
EQUITY Posted on Nov 13th 2026

Gujarat Fluorochemicals informs about acquisition

Gujarat Fluorochemicals has informed that GFCL EV Products, Material Subsidiary of the Company has incorporated its Wholly-owned Subsidiary Company, GFCL EV Critical Minerals on 12th November, 2026. Additional details required to be disclosed pursuant to Regulation 30 read with read with sub-para 1 of Para A of Part A of Schedule III of the Listing Regulations and in terms of SEBI’s Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 are enclosed as Annexure A.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Mahamaya Lifesciences Ltd. ?

The current share price of Mahamaya Lifesciences Ltd. is ₹188.55 as of 2026-11-13.

The market capitalisation of Mahamaya Lifesciences Ltd. is ₹441.30 as of 2026-11-13.

The 1-year return of Mahamaya Lifesciences Ltd. is % as of .

The P/E ratio of Mahamaya Lifesciences Ltd. is 21.32 as of 2026-11-14.

The 52-week high and low of Mahamaya Lifesciences Ltd. are ₹205.05 and ₹111.00, respectively, as of 2026-11-13.

The dividend yield of Mahamaya Lifesciences Ltd. is 0.0% as of2026-11-13.

You can buy Mahamaya Lifesciences Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Mahamaya Lifesciences Ltd. is Krishnamurthy Ganesan.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore